FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C
August 02, 2024 17:50 ET
|
Zevra Therapeutics
CELEBRATION, Fla., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that the U.S. Food and...
Talen Statement on FERC’s Issuance of a Deficiency Letter Regarding Susquehanna ISA and New Generic Proceeding Initiating a Commissioner-led Technical Conference
August 02, 2024 17:46 ET
|
Talen Energy Corporation
HOUSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Talen Energy Corporation ("Talen") (NASDAQ: TLN) issued the following statements in response to the Federal Energy Regulatory Commission (the “FERC”) today...
Helport AI Limited and Tristar Acquisition I Corp. Announce Closing on Reduced $5.5 Million PIPE Investment Concurrently with Closing of Business Combination
August 02, 2024 17:07 ET
|
Helport AI Limited
SINGAPORE and BURLINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Helport AI Limited (together with its operating subsidiaries, “Helport”), an AI technology company serving enterprises’ customer...
JOYY Announces Leadership Transition
August 02, 2024 17:00 ET
|
JOYY Inc.
SINGAPORE, Aug. 03, 2024 (GLOBE NEWSWIRE) -- JOYY Inc. (Nasdaq: YY) (“JOYY” or the “Company”), a global technology company, today announced that its board of directors (the “Board”) has approved a...
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
August 02, 2024 16:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
Arhaus Unveils Studio in Peachtree City, Georgia
August 02, 2024 16:30 ET
|
Arhaus, Inc.
BOSTON HEIGHTS, Ohio, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Arhaus, a leader in artisan-crafted furniture and home décor, announces the opening of its new 7,085 square-foot Studio at The Avenue...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024 16:30 ET
|
ORIC Pharmaceuticals
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024 16:30 ET
|
Olema Oncology
SAN FRANCISCO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
August 02, 2024 16:30 ET
|
DBV Technologies S.A.
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés...
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2024
August 02, 2024 16:30 ET
|
DBV Technologies S.A.
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2024 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place...